These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37543428)

  • 1. Development of anoikis-related long non-coding RNA signature associated with prognosis and immune landscape in cutaneous melanoma patients.
    Zhong L; Qian W; Gong W; Zhu L; Zhu J
    Aging (Albany NY); 2023 Aug; 15(15):7655-7672. PubMed ID: 37543428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs.
    Zhang M; Zuo Y; Guo J; Yang L; Wang Y; Tan M; Guo X
    Sci Rep; 2023 Sep; 13(1):16332. PubMed ID: 37770477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anoikis-related long non-coding RNA signatures to predict prognosis and small molecular drug response in cervical cancer.
    Liang H; Xiang L; Wu H; Liu Y; Tian W; Zeng J
    Front Pharmacol; 2023; 14():1135626. PubMed ID: 37021052
    [No Abstract]   [Full Text] [Related]  

  • 4. An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma.
    Jiang X; Gao YL; Li JY; Tong YY; Meng ZY; Yang SG; Zhu CT
    Heliyon; 2023 Nov; 9(11):e22200. PubMed ID: 38053861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
    Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
    Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A promising anoikis-related prognostic signature predicts prognosis of skin cutaneous melanoma.
    Yue Z; Wang D; Li X
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17757-17770. PubMed ID: 37930439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and identification of anoikis-related lncRNA signatures for improving prognosis in clear cell renal cell carcinoma.
    Zhu Z; Wang Q; Zeng X; Zhu S; Chen J
    Aging (Albany NY); 2024 Feb; 16(4):3915-3933. PubMed ID: 38385949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy.
    Zhang YY; Li XW; Li XD; Zhou TT; Chen C; Liu JW; Wang L; Jiang X; Wang L; Liu M; Zhao YG; Li SD
    Front Immunol; 2022; 13():1055304. PubMed ID: 36505486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the prognostic significance of anoikis-related lncRNAs in invasive breast cancer: from comprehensive bioinformatics analysis to functional experimental validation.
    Dong W; Li J; Zhuang Z
    Aging (Albany NY); 2024 Jan; 16(1):402-430. PubMed ID: 38189818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub anoikis-associated genes and risk signature in cutaneous melanoma.
    He YW; Fan QP; Hua AL; Liu Q
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5662-5676. PubMed ID: 37401304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and experimental validation of hypoxia-related long noncoding RNAs prognostic signature in predicting prognosis and immunotherapy of cutaneous melanoma.
    Wang G; Sun Y; Xu Q
    Aging (Albany NY); 2023 Nov; 15(21):11918-11939. PubMed ID: 37921852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
    Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients.
    Li Q; Zhang H; Hu J; Zhang L; Zhao A; Feng H
    Front Pharmacol; 2023; 14():1124262. PubMed ID: 36925640
    [No Abstract]   [Full Text] [Related]  

  • 15. Anoikis patterns via machine learning strategy and experimental verification exhibit distinct prognostic and immune landscapes in melanoma.
    Liu J; Ma R; Chen S; Lai Y; Liu G
    Clin Transl Oncol; 2024 May; 26(5):1170-1186. PubMed ID: 37989822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New algorithms based on autophagy-related lncRNAs pairs to predict the prognosis of skin cutaneous melanoma patients.
    Liu Y; Zhang H; Hu D; Liu S
    Arch Dermatol Res; 2023 Aug; 315(6):1511-1526. PubMed ID: 36624362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
    Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
    Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
    Tian J; Yang Y; Li MY; Zhang Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hypoxic-related lncRNAs prognostic model for revealing clinical prognostic and immune infiltration characteristic of cutaneous melanoma.
    Liao C; Yang J; Chen L; Ye Z
    Aging (Albany NY); 2024 Feb; 16(4):3734-3749. PubMed ID: 38364250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel risk model based on anoikis: Predicting prognosis and immune infiltration in cutaneous melanoma.
    Zhou Y; Wang C; Chen Y; Zhang W; Fu Z; Li J; Zheng J; Xie M
    Front Pharmacol; 2022; 13():1090857. PubMed ID: 36726781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.